Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-28T06:34:19.632Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of Vaporized Hydrogen Peroxide Decontamination during an Outbreak of Multidrug-Resistant Acinetobacter baumannii Infection at a Long-Term Acute Care Hospital

Published online by Cambridge University Press:  02 January 2015

Amy Ray ,
Federico Perez ,
Amanda M. Beltramini ,
Marta Jakubowycz ,
Patricia Dimick ,
Michael R. Jacobs ,
Kathy Roman ,
Robert A. Bonomo  and
Robert A. Salata
Amy Ray*
Affiliation:
Division of Infectious Diseases and HIV Medicine, University Hospitals Case Medical Center, Cleveland, Ohio
Federico Perez
Affiliation:
Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio
Amanda M. Beltramini
Affiliation:
Division of Infectious Diseases and HIV Medicine, University Hospitals Case Medical Center, Cleveland, Ohio
Marta Jakubowycz
Affiliation:
Division of Infectious Diseases and HIV Medicine, University Hospitals Case Medical Center, Cleveland, Ohio
Patricia Dimick
Affiliation:
Division of Infectious Diseases and HIV Medicine, University Hospitals Case Medical Center, Cleveland, Ohio
Michael R. Jacobs
Affiliation:
Division of Infectious Diseases and HIV Medicine, University Hospitals Case Medical Center, Cleveland, Ohio
Kathy Roman
Affiliation:
Division of Infectious Diseases and HIV Medicine, University Hospitals Case Medical Center, Cleveland, Ohio
Robert A. Bonomo
Affiliation:
Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio
Robert A. Salata
Affiliation:
Division of Infectious Diseases and HIV Medicine, University Hospitals Case Medical Center, Cleveland, Ohio
*
University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, OH 44106-5083, ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives.

To describe vaporized hydrogen peroxide (VHP) as an adjuvant in the control of multidrug-resistant (MDR) Acinetobacter baumannii infection in a long-term acute care hospital (LTACH) and to describe the risk factors for acquisition of MDR A. baumannii infection in the LTACH population.

Design.

Outbreak investigation, case-control study, and before-after intervention trial.

Setting.

A 54-bed LTACH affiliated with a tertiary care center in northeastern Ohio.

Methods.

Investigation of outbreak with clinical and environmental cultures, antimicrobial susceptibility testing, polymerase chain reaction assay of repetitive chromosomal elements to type strains, and case-control study; and intervention consisting of comprehensive infection control measures and VHP environmental decontamination.

Results.

Thirteen patients infected or colonized with MDR A. baumannii were identified from January 2008 through June 2008. By susceptibility testing, 10 (77%) of the 13 isolates were carbapenem-resistant. MDR A. baumannii was found in wound samples, blood, sputum, and urine. Wounds were identified as a risk factor for MDR A. baumannii colonization. Ventilator-associated pneumonia was the most common clinical syndrome caused by the pathogen, and the associated mortality was 14% (2 of the 13 case patients died). MDR A. baumannii was found in 8 of 93 environmental samples, including patient rooms and a wound care cart; environmental and clinical cultures were genetically related. Environmental cultures were negative immediately after VHP decontamination and both 24 hours and 1 week after VHP decontamination. Nosocomial acquisition of the pathogen in the LTACH ceased after VHP Intervention. When patients colonized with MDR A. baumannii reoccupied rooms, environmental contamination recurred.

Conclusion.

Environmental decontamination using VHP combined with comprehensive infection control measures interrupted nosocomial transmission of MDR A. baumannii in an LTACH. The application of this novel approach to halt the transmission of MDR A. baumannii warrants further investigation.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 31 , Issue 12 , December 2010 , pp. 1236 - 1241
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Hidron, AI, Edwards, JR, Patel, J, et al.NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29(11):996–1011.CrossRefGoogle Scholar
2.Munoz-Price, LS, Weinstein, RA. Acinetobacter infection. N Engl J Med 2008;358(12):1271–1281.CrossRefGoogle ScholarPubMed
3.Jawad, A, Seifert, H, Snelling, AM, Heritage, J, Hawkey, PM. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol 1998;36(7):1938–1941.Google Scholar
4.Wendt, C, Dietze, B, Dietz, E, Ruden, H. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol 1997;35(6):1394–1397.CrossRefGoogle ScholarPubMed
5.Villegas, MV, Hartstein, AI. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol 2003;24(4):284–295.CrossRefGoogle ScholarPubMed
6.Peleg, AY, Seifert, H, Paterson, DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008;21(3):538–582.Google Scholar
7.Perez, F, Hujer, AM, Hujer, KM, Decker, BK, Rather, PN, Bonomo, RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007;51(10):3471–3484.Google Scholar
8.Otter, JA, Cummins, M, Ahmad, F, van Tonder, C, Drabu, YJ. Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination. J Hosp Infect 2007;67(2):182–188.Google Scholar
9.Kahnert, A, Seiler, P, Stein, M, Aze Β, McDonnell, G, Kaufmann, SH. Decontamination with vaporized hydrogen peroxide is effective against Mycobacterium tuberculosis. Lett Appl Microbiol 2005;40(6):448–452.CrossRefGoogle ScholarPubMed
10.Otter, JA, Puchowicz, M, Ryan, D, et al.Feasibility of routinely using hydrogen peroxide vapor to decontaminate rooms in a busy United States hospital. Infect Control Hosp Epidemiol 2009;30(6):574–577.Google Scholar
11.Blythe, D, Keenlyside, D, Dawson, SJ, Galloway, A. Environmental contamination due to methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 1998;38(1):67–69.CrossRefGoogle ScholarPubMed
12.Hardy, KJ, Gossain, S, Henderson Ν, et al.Rapid recontamination with MRSA of the environment of an intensive care unit after decontamination with hydrogen peroxide vapour. J Hosp Infect 2007;66(4):360–368.Google Scholar
13.Maragakis, LL, Cosgrove, SE, Song, X, et al.An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment. JAMA 2004;292(24):3006–3011.Google Scholar
14.Clinical Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: 18th Informational Supplement. M100-S18. Wayne, PA: CLSI, 2008.Google Scholar
15.Saeed, S, Fakih, MG, Riederer, K, Shah, AR, Khatib, R. Interinstitutional and intrainstitutional transmission of a strain of Acinetobacter baumannii detected by molecular analysis: comparison of pulsed-field gel electrophoresis and repetitive sequence-based polymerase chain reaction. Infect Control Hosp Epidemiol 2006;27(9):981–983.Google Scholar
16.Higgins, PG, Dammhayn, C, Hackel, M, Seifert, H. Global spread of carbapenem-resistant Acinetobacter baumannii. I Antimicrob Chemother 2010;65(2):233–238.CrossRefGoogle ScholarPubMed
17.Hamill, RJ, Houston, ED, Georghiou, PR, et al.An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med 1995;122(10):762–766.Google Scholar
18.Wexler, MR, Rhame, FS, Blumenthal, MN, Cameron, SB, Juni, BA, Fish, LA. Transmission of gram-negative bacilli to asthmatic children via home nebulizers. Ann Allergy 1991;66(3):267–271.Google ScholarPubMed
19. Medicare Payment Advisory Commission. Medpac home page, http://www.medpac.gov. Published 2003. Accessed March 9, 2010.Google Scholar
20.Carson, SS, Bach, PB, Brzozowski, L, Leff, A. Outcomes after long-term acute care: an analysis of 133 mechanically ventilated patients. Am J Respir Crit Care Med 1999;159(5 Pt 1):1568–1573.Google Scholar
21.Munoz-Price, LS. Long-term acute care hospitals. Clin Infect Dis 2009;49(3):438–443.Google Scholar
22.Furuno, JP, Hebden, JN, Standiford, HC, et al.Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facility. Am J Infect Control 2008;36(7):468–471.CrossRefGoogle Scholar
23.Stephens, C, Francis, SJ, Abell, V, DiPersio, JR, Wells, P. Emergence of resistant Acinetobacter baumannii in critically ill patients within an acute care teaching hospital and a long-term acute care hospital. Am J Infect Control 2007;35(4):212–215.CrossRefGoogle Scholar
24.Lolans, K, Rice, TW, Munoz-Price, LS, Quinn, JP. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agents Chemother 2006;50(9):2941–2945.CrossRefGoogle ScholarPubMed
25.Rodriguez-Bano, J, Garcia, L, Ramirez, E, et al.Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive “bundle” approach. Am J Infect Control 2009;37(9):715–722.CrossRefGoogle ScholarPubMed
26.Apisarnthanarak, A, Pinitchai, U, Thongphubeth, K, Yuekyen, C, Warren, DK, Fraser, VJ. A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study. Clin Infect Dis 2008;47(6):760–767.Google Scholar
27.Rutala, WA. APIC guideline for selection and use of disinfectants. 1994, 1995, and 1996 APIC Guidelines Committee. Association for Professionals in Infection Control and Epidemiology, Inc. Am J Infect Control 1996;24(4):313–342.CrossRefGoogle ScholarPubMed
28.Wisplinghoff, H, Schmitt, R, Wohrmann, A, Stefanik, D, Seifert, H. Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii. J Hosp Infect 2007;66(2):174–181.Google Scholar